zoledronic acid has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebeling, PR; Nerlekar, N; RodrÃguez, AJ | 1 |
| Avcu, F; Baran, Y; Ural, AU | 1 |
2 other study(ies) available for zoledronic acid and Coronary Artery Disease
| Article | Year |
|---|---|
Cardiac adverse events in bisphosphonate and teriparatide users: An international pharmacovigilance study.
Topics: Alendronate; Bone Density Conservation Agents; Coronary Artery Disease; Diphosphonates; DNA-Binding Proteins; Humans; Osteoporosis; Pharmacovigilance; Teriparatide; Zoledronic Acid | 2023 |
Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.
Topics: Animals; Bone Density Conservation Agents; Breast Neoplasms; Coronary Artery Disease; Diphosphonates; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Myocardial Infarction; Risk Factors; Zoledronic Acid | 2007 |